Investing News NetworkYour trusted source for investing success

Videos
Companies
Press Releases
Top Stocks
Top Resource Stocks
Top Tech Stocks
Top Life Science Stocks
Private Placements
Trending
Trending Articles

Is Now a Good Time to Buy Bitcoin? (Updated 2023)

Is the World Running Out of Copper? (Updated 2023)

10 Generative AI Stocks to Watch as ChatGPT Soars (Updated 2023)

Where Does Tesla Get its Lithium? (Updated 2023)

When Will Silver Go Up? (Updated 2023)

Top 10 Oil-producing Countries (Updated 2023)

7 Biggest Lithium-mining Companies in 2023

Uranium Reserves: Top 5 Countries (Updated 2023)

Is Now a Good Time to Buy Lithium Stocks?

Trending Press Releases

AVL and TMT Agree A$217 Million Merger

Alpha Lithium Files Improved Preliminary Economic Assessment and Provides Update on Strategic Review Process

FPX Nickel Announces Battery Supply Chain MOU with JOGMEC and Prime Planet Energy & Solutions

Max Resource Discovers New Copper & Silver Target at CESAR

Nano One Announces Collaboration Agreement with Sumitomo Metal Mining and a C$16.9 Million Strategic Investment

Helium Evolution's Farmout Well Encounters Helium, Proceeding With Completion and Testing

More Press Releases
Trending Companies

Beyond Lithium

BY:CC

Australian Vanadium

ATVVF

BHP Group Ltd

BHP:AU

Albemarle Corporation

ALB
More Companies
Trending Reports

2023 AI Outlook Report (Updated!)

2023 Lithium Investor Report (Updated!)

2023 Uranium Outlook Report (Updated!)

2023 Oil & Gas Outlook Report (Updated!)

More Outlook Reports
Resource
Resource
Popular Lists
Investing Ideas
2023 Outlook Reports
Investing Guides
Tech
Tech
Popular Lists
Investing Ideas
2023 Outlook Reports
Investing Guides
Life Science
Life Science
Popular Lists
Investing Ideas
2023 Outlook Reports
Investing Guides
Artificial Intelligence
Oil & Gas
Battery Metals
Uranium
BRICS Currency
Tesla
loader

coherus biosciences

LATEST ARTICLES
An Investor’s Overview to Biosimilars
Biotech Investing

An Investor’s Overview to Biosimilars

Company News

Coherus BioSciences Announces Global Settlement with AbbVie

Pharmaceutical Investing

Coherus BioSciences Announces Positive Topline 24-Week Treatment Phase Three Results for CHS-1420 (HUMIRA® Biosimilar Candidate) in Patients with Psoriasis

Biotech Investing

Coherus BioSciences Announces FDA Acceptance of 351(k) Biologics License Application for CHS-1701

Company News

Coherus Announces Positive Phase 2b Efficacy Data on Novel Oral Therapy in Relapsing Remitting Multiple Sclerosis

Biotech Investing

Coherus BioSciences Provides Update on ‘135 IPR

Biotech Investing

Coherus BioSciences to Present at Bank of America Merrill Lynch Health Care Conference on May 11

MARKETS

Markets
TSX19556.15-244.46
TSXV557.05-13.12
DOW33618.88-388.00
S&P 5004273.530.00
NASD13063.610.00
ASX7038.20-38.30

COMMODITIES

Commodities
Gold1891.44-10.28
Silver22.68-0.16
Copper3.64-0.01
Palladium1713.170.00
Platinum1087.260.00
Oil92.28+1.89
Heating Oil3.18+0.01
Natural Gas2.67+0.01

DOWNLOAD FREE REPORTS

BROWSE COMPANIES BY SECTOR